KR20110051268A - 락토바실러스 박테리아 유래 면역조절 추출물 및 이의 제조 방법 및 이의 용도 - Google Patents

락토바실러스 박테리아 유래 면역조절 추출물 및 이의 제조 방법 및 이의 용도 Download PDF

Info

Publication number
KR20110051268A
KR20110051268A KR1020117007527A KR20117007527A KR20110051268A KR 20110051268 A KR20110051268 A KR 20110051268A KR 1020117007527 A KR1020117007527 A KR 1020117007527A KR 20117007527 A KR20117007527 A KR 20117007527A KR 20110051268 A KR20110051268 A KR 20110051268A
Authority
KR
South Korea
Prior art keywords
lactobacillus
extract
hours
bacterial
extracts
Prior art date
Application number
KR1020117007527A
Other languages
English (en)
Korean (ko)
Inventor
제쿠에스 알라인 바우어
마르코 살바니
쟝-피엘 레온 비그로우스
라에티샤 릴라 기세레 샤벳
카를로 샤바롤리
Original Assignee
오엠 파르마
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오엠 파르마 filed Critical 오엠 파르마
Publication of KR20110051268A publication Critical patent/KR20110051268A/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020117007527A 2008-09-04 2008-09-04 락토바실러스 박테리아 유래 면역조절 추출물 및 이의 제조 방법 및 이의 용도 KR20110051268A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/010350 WO2010027344A1 (en) 2008-09-04 2008-09-04 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

Publications (1)

Publication Number Publication Date
KR20110051268A true KR20110051268A (ko) 2011-05-17

Family

ID=41797341

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117007527A KR20110051268A (ko) 2008-09-04 2008-09-04 락토바실러스 박테리아 유래 면역조절 추출물 및 이의 제조 방법 및 이의 용도

Country Status (11)

Country Link
JP (1) JP2012502026A (pt)
KR (1) KR20110051268A (pt)
CN (1) CN102143756A (pt)
AU (1) AU2008361375B2 (pt)
BR (1) BRPI0822997A2 (pt)
CA (1) CA2733249A1 (pt)
IL (1) IL211041A0 (pt)
MX (1) MX2011002080A (pt)
RU (1) RU2500412C2 (pt)
WO (1) WO2010027344A1 (pt)
ZA (1) ZA201100899B (pt)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150146331A (ko) * 2014-06-23 2015-12-31 한국식품연구원 락토바실러스 속 균주의 면역증강 활성을 증가시키는 배양 방법
KR20200103219A (ko) * 2019-02-22 2020-09-02 가톨릭대학교 산학협력단 마이크로바이옴 혼합물을 포함하는 면역 질환의 예방 및 치료용 조성물
KR20220075622A (ko) * 2020-11-30 2022-06-08 나눔제약 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
KR20230001127A (ko) 2021-06-28 2023-01-04 농업회사법인 산청바이오진생마을 주식회사 새싹 인삼 라떼 제조방법
WO2023167563A1 (ko) * 2022-03-03 2023-09-07 한국생명공학연구원 N-카바밀-l-글루탐산을 포함하는 염증성 질환의 치료용 조성물

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2670415A4 (en) * 2011-02-02 2014-11-26 Justbio Inc FUNCTIONAL FOODS AND BEVERAGES WITH SYNERGISTIC PROPERTIES FOR THE PROMOTION OF HOMEOSTASIS
JP6014652B2 (ja) * 2011-03-29 2016-10-25 ネステク ソシエテ アノニム Ｄ−乳酸産生が欠損し、保存期間が改善した、ラクトバチルスジョンソニー（Ｌａｃｔｏｂａｃｉｌｌｕｓｊｏｈｎｓｏｎｉｉ）ＣＮＣＭＩ−１２２５株の天然変異体
BR112013024831A2 (pt) * 2011-03-29 2016-12-20 Nestec Sa derivado natural da cepa cncm i-1225 de lactobacillus johnsonii, deficiente na produção de ácido d=láctico e com um perfil imunológico mais incrementado
US20130022586A1 (en) 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
JP6632802B2 (ja) 2012-01-16 2020-01-22 マッケンナ，エリザベス 肝疾患及び肝障害を治療するための組成物及び方法
WO2014047588A1 (en) 2012-09-21 2014-03-27 Elizabeth Mckenna Naturally occurring cpg oligonucleotide compositions and therapeutic applications thereof
US20150017208A1 (en) * 2013-07-12 2015-01-15 National Yang-Ming University Lactic acid bacterium having immunomodulatory and anti-allergic effects
JP6821643B2 (ja) * 2013-09-26 2021-01-27 雪印メグミルク株式会社 免疫疾患予防剤
JP6491422B2 (ja) * 2013-09-26 2019-03-27 雪印メグミルク株式会社 免疫疾患予防剤
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
JP6940305B2 (ja) * 2017-06-01 2021-09-22 株式会社明治 チーズ風味素材の製造方法
KR102335710B1 (ko) 2017-10-31 2021-12-07 (주)아모레퍼시픽 유산균 유래의 세포밖 베지클을 포함하는 면역조절용 조성물
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
EP3792342A4 (en) 2018-05-09 2022-01-12 Kobiolabs, Inc. LACTOBACILLUS PARACASEI STRAIN AND ITS USE
CN112469404A (zh) * 2018-06-07 2021-03-09 国立大学法人金泽大学 肾损伤的预防或治疗用的药物组合物
TW202011834A (zh) * 2018-06-07 2020-04-01 國立大學法人金澤大學 腎損傷之預防或治療用之醫藥組合物
CN109007842A (zh) * 2018-10-29 2018-12-18 广州普维君健药业有限公司 具有防治过敏功效的益生菌组合物及其应用
CN109628359B (zh) * 2019-02-22 2021-03-02 江南大学 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用
EP3937957A1 (en) * 2019-03-14 2022-01-19 OM Pharma SA Process for making stable bacterial extracts and their use as pharmaceuticals
CN110643541B (zh) * 2019-10-25 2021-08-24 江南大学 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
CN111053789A (zh) * 2019-11-26 2020-04-24 湖南营养树生物科技有限公司 调节免疫系统的方法和组合物
EP4084784A4 (en) * 2020-01-13 2024-01-17 Univ Monash COMPOSITIONS AND METHODS
CN111548961A (zh) * 2020-05-15 2020-08-18 郑州和合生物工程技术有限公司 改善过敏性疾病的益生菌组合物、益生菌组合物菌粉及制备方法，应用
CN111991428A (zh) * 2020-06-12 2020-11-27 郑州和合生物工程技术有限公司 一种具有改善哮喘作用的益生菌组合物及其制备方法
CN112057479B (zh) * 2020-11-16 2021-02-12 河北一然生物科技有限公司 一种能够缓解抗生素引起腹泻的益生菌组合物
CN114774302B (zh) * 2022-03-09 2023-06-16 善恩康生物科技（苏州）有限公司 植物乳杆菌cqpc02在制备用于预防和/或治疗狼疮性肾炎的产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532903A (fr) * 1971-06-25 1973-01-31 Nestle Sa Procédé d'extraction de protéines à partir de cellules de microorganismes
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
RU2302458C2 (ru) * 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Пробиотический штамм lactobacillus salivarius (варианты), пробиотический препарат на их основе и способ лечения или предупреждения с использованием штаммов lactobacillus salivarius
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
EP1722804B1 (en) * 2004-03-04 2015-01-21 E-L Management Corp. Skin treatment method with lactobacillus extract
CA2609617C (en) * 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン１０産生促進剤

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150146331A (ko) * 2014-06-23 2015-12-31 한국식품연구원 락토바실러스 속 균주의 면역증강 활성을 증가시키는 배양 방법
KR20200103219A (ko) * 2019-02-22 2020-09-02 가톨릭대학교 산학협력단 마이크로바이옴 혼합물을 포함하는 면역 질환의 예방 및 치료용 조성물
KR20220075622A (ko) * 2020-11-30 2022-06-08 나눔제약 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
KR20230001127A (ko) 2021-06-28 2023-01-04 농업회사법인 산청바이오진생마을 주식회사 새싹 인삼 라떼 제조방법
WO2023167563A1 (ko) * 2022-03-03 2023-09-07 한국생명공학연구원 N-카바밀-l-글루탐산을 포함하는 염증성 질환의 치료용 조성물

Also Published As

Publication number Publication date
CA2733249A1 (en) 2010-03-11
BRPI0822997A2 (pt) 2015-06-23
IL211041A0 (en) 2011-04-28
MX2011002080A (es) 2011-03-29
JP2012502026A (ja) 2012-01-26
CN102143756A (zh) 2011-08-03
RU2500412C2 (ru) 2013-12-10
WO2010027344A1 (en) 2010-03-11
ZA201100899B (en) 2012-05-30
RU2011112781A (ru) 2012-10-10
AU2008361375B2 (en) 2014-05-22
AU2008361375A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
KR20110051268A (ko) 락토바실러스 박테리아 유래 면역조절 추출물 및 이의 제조 방법 및 이의 용도
AU2008222865B2 (en) Bacterial extract for respiratory disorders and proces for its preparation
Galdeano et al. Mechanisms involved in the immunostimulation by probiotic fermented milk
SG177743A1 (en) Novel lactobacillus plantarum and composition comprising same
US9198961B2 (en) Bacterial extract for digestive or urinary tract disorders and process for its preparation
ES2345188T3 (es) Preparaciones de bacterias gram positivas para el tratamiento de enfermedades que comprenden una mala regulacion inmune.
KR20190049792A (ko) 면역자극 특성을 가진 비피도박테리움 속에 속하는 프로바이오틱 박테리아 균주 및 이의 프로바이오틱 세포 추출물 (pces)
RU2722038C2 (ru) Пробиотические штаммы, обладающие способностью поглощать холестерин, способы и их применение
KR20220007609A (ko) 프로바이오틱 박테리아의 치료요법적 미세소포
US20100055082A1 (en) Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
EP2540818A1 (en) Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
Villena et al. Immunobiotics for the prevention of bacterial and viral respiratory infections
TW201010711A (en) Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
AU2013200193B2 (en) Bacterial extract for digestive or urinary tract disorders and process for its preparation
JP2024025452A (ja) 機能的免疫賦活乳酸菌
Stamatova et al. Probiotic challenge of oral epithelial cells in vitro
Підгорський et al. EFFECTS OF DRY ENZYMATIC LYSATE DEL-IMMUNE V® ON CYTOKINE PRODUCTION IN THE EXPERIMENTAL MODELS
ITMI20070597A1 (it) Metodo di frazionamento di organismi unicellulari e prodotti ottenuti da tale processo

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application